Regorafenib (BAY 73-4506): A new oral multikinase inhibitor...

Regorafenib (BAY 73-4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity

Scott M. Wilhelm, Jacques Dumas, Lila Adnane, Mark Lynch, Christopher A. Carter, Gunnar Schütz, Karl-Heinz Thierauch, Dieter Zopf
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
129
Year:
2011
Language:
english
Pages:
11
DOI:
10.1002/ijc.25864
File:
PDF, 1.30 MB
english, 2011
Conversion to is in progress
Conversion to is failed